Out Fox The $treet

  Ascend Wellness remains an undiscovered cannabis MSO with very few followers on financial websites. The company has an attractive set of licenses including a deal to acquire the MedMen license in New York. The stock only trades at 8x '22 EBITDA targets despite estimates for revenues to double next year. Looking for a portfolio of ideas like this one? Members of Out Fox The Street get exclusive access to our model portfolio.  Learn More » The cannabis space is now full of 2nd tier MSOs (multi-state operators) ripe for acquisition targets. Another example is  Ascend Wellness Holdings  ( OTCQX:AAWH ) that went public quietly back earlier this year. My investment thesis is very Bullish on the stock, but more proven opportunities exist in the U.S. cannabis market. Read the full article on Seeking Alpha.  Disclosure: No position mentioned. Please review the disclaimer page for more details.  Update - Oct. 6 Good news for the NY license. -Meeting for the first ...

  Goodness Growth was lost in the shuffle following a name change and new growth initiatives. The MSO forecasts 2022 revenue of $140 to $180 million for a company exiting Q1 at a $53 million annual run rate. The company owns one of the 10 licenses in New York. The stock trades at only ~6x 2022 EBITDA targets, though a lot is unproven about that target. Looking for a portfolio of ideas like this one? Members of Out Fox The Street get exclusive access to our model portfolio.  Learn More » Vireo Health International changed their name to Goodness Growth Holdings  ( OTCQX:GDNSF )  and the cannabis stock hasn't reacted very well to the new name. With the stock down to $1.70, the market valuation hardly exceeds the value of their license in New York. After this dip and the expanded focus of the business, my  investment thesis  is more bullish on the stock. Read the full article on Seeking Alpha.  Disclosure: No position mentioned. Please review the disclaim...